Preferred Label : 17 alpha-Hydroxyprogesterone Caproate;

MeSH definition : Hydroxyprogesterone derivative that acts as a PROGESTIN and is used to reduce the risk of recurrent MISCARRIAGE and of PREMATURE BIRTH. It is also used in combination with ESTROGEN in the management of MENSTRUATION DISORDERS.;

MeSH synonym : 17 alpha Hydroxyprogesterone Caproate; 17-alpha-Hydroxy-Progesterone Caproate; 17 alpha Hydroxy Progesterone Caproate; Caproate, 17-alpha-Hydroxy-Progesterone; Oxyprogesterone Caproate; Hydroxyprogesterone Caproate; Hydroxyprogesterone Hexanoate; 17 alpha-Oxyprogesterone Capronate; 17 alpha Oxyprogesterone Capronate; 17-Hydroxyprogesterone Capronate; 17 Hydroxyprogesterone Capronate;

MeSH hyponym : Proluton Depot;

MeSH CAS label : Hexanoic acid, 3,20-dioxopregn-4-en-17-yl ester;

MeSH Related Number : 630-56-8;

Wikipedia link : https://en.wikipedia.org/wiki/17-alpha-Hydroxy-Progesterone Caproate;

UNII : 276F2O42F5;

Details


Main resources

You can consult :

Hydroxyprogesterone derivative that acts as a PROGESTIN and is used to reduce the risk of recurrent MISCARRIAGE and of PREMATURE BIRTH. It is also used in combination with ESTROGEN in the management of MENSTRUATION DISORDERS.

https://ansm.sante.fr/actualites/retour-dinformation-sur-le-prac-de-mai-2024-13-16-mai
2024
false
false
false
France
French
drug information
Safety-Based drug withdrawals
17 alpha-Hydroxyprogesterone Caproate
europe

---
https://ansm.sante.fr/informations-de-securite/suspension-des-autorisations-de-mise-sur-le-marche-des-medicaments-contenant-du-caproate-dhydroxyprogesterone
2024
false
false
false
France
French
pharmacovigilance note
Safety-Based drug withdrawals
17 alpha-Hydroxyprogesterone Caproate
injections, intramuscular
Delayed-Action preparations
progestins
hydroxyprogesterone
neoplasms
prenatal exposure delayed effects
In Utero Drug Exposure
guideline

---
https://ansm.sante.fr/actualites/lautorisation-de-mise-sur-le-marche-du-medicament-progesterone-retard-pharlon-caproate-dhydroxyprogesterone-est-suspendue
2024
false
false
false
France
French
pharmacovigilance note
Safety-Based drug withdrawals
17 alpha-Hydroxyprogesterone Caproate
injections, intramuscular
Delayed-Action preparations
progestins
hydroxyprogesterone
neoplasms
prenatal exposure delayed effects
In Utero Drug Exposure

---
Nous contacter.
05/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.